Skip to main content
Journal cover image

Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation.

Publication ,  Journal Article
Newby, LK; Bhapkar, MV; White, HD; Moliterno, DJ; LaPointe, NMA; Kandzari, DE; Verheugt, FWA; Kramer, JM; Armstrong, PW; Califf, RM ...
Published in: J Thromb Thrombolysis
December 2003

BACKGROUND: While aspirin's secondary prevention benefit is clear, prior reports indicate that 19-83% of eligible patients may not use aspirin chronically. METHODS: We investigated intolerance and bleeding while on aspirin and aspirin discontinuation using 5337 post-acute coronary syndrome patients considered appropriate for chronic antiplatelet therapy who were randomly assigned to aspirin in SYMPHONY and 2nd SYMPHONY and followed for 94 (64,157) days. Multivariable logistic regression models tested associations between baseline characteristics and aspirin discontinuation and bleeding. RESULTS: Nearly 18% of patients discontinued study aspirin; 48% subsequently used open-label aspirin and 5% other antiplatelet or anticoagulant therapy. Black race, recurrent ischemia, hypertension, chronic obstructive pulmonary disease, lighter weight, shorter time to treatment and use of non-steroidal anti-inflammatory agents, diuretics, and digitalis were independently associated with early discontinuation. Early discontinuation was less likely in Eastern Europe, Latin America and Asia. Although major or minor bleeding was common (12.6%), only 1.0% of aspirin-treated patients were reported to discontinue due to bleeding. Gastrointestinal (10.5%) and puncture site (7.6%) were the most common bleeding locations. Bleeding risk was associated with lower estimated creatinine clearance, shorter time to treatment, smoking, Killip class >II, higher systolic blood pressure, and use of aspirin or heparin prior to starting study aspirin. CONCLUSIONS: Despite early initiation and close follow-up, more than 9% of aspirin-treated patients discontinued therapy early and remained off treatment. Addressing the factors associated with both bleeding and discontinuation during chronic therapy is necessary to improve adherence to this inexpensive, life-saving therapy.

Duke Scholars

Published In

J Thromb Thrombolysis

DOI

ISSN

0929-5305

Publication Date

December 2003

Volume

16

Issue

3

Start / End Page

119 / 128

Location

Netherlands

Related Subject Headings

  • Risk Factors
  • Patient Compliance
  • Odds Ratio
  • Middle Aged
  • Male
  • Kidney Function Tests
  • Humans
  • Hemorrhage
  • Female
  • Coronary Disease
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Newby, L. K., Bhapkar, M. V., White, H. D., Moliterno, D. J., LaPointe, N. M. A., Kandzari, D. E., … SYMPHONY and 2nd SYMPHONY investigators, . (2003). Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation. J Thromb Thrombolysis, 16(3), 119–128. https://doi.org/10.1023/B:THRO.0000024050.78728.35
Newby, L Kristin, Manjushri V. Bhapkar, Harvey D. White, David J. Moliterno, Nancy M Allen LaPointe, David E. Kandzari, Freek W. A. Verheugt, et al. “Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation.J Thromb Thrombolysis 16, no. 3 (December 2003): 119–28. https://doi.org/10.1023/B:THRO.0000024050.78728.35.
Newby LK, Bhapkar MV, White HD, Moliterno DJ, LaPointe NMA, Kandzari DE, et al. Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation. J Thromb Thrombolysis. 2003 Dec;16(3):119–28.
Newby, L. Kristin, et al. “Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation.J Thromb Thrombolysis, vol. 16, no. 3, Dec. 2003, pp. 119–28. Pubmed, doi:10.1023/B:THRO.0000024050.78728.35.
Newby LK, Bhapkar MV, White HD, Moliterno DJ, LaPointe NMA, Kandzari DE, Verheugt FWA, Kramer JM, Armstrong PW, Califf RM, SYMPHONY and 2nd SYMPHONY investigators. Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation. J Thromb Thrombolysis. 2003 Dec;16(3):119–128.
Journal cover image

Published In

J Thromb Thrombolysis

DOI

ISSN

0929-5305

Publication Date

December 2003

Volume

16

Issue

3

Start / End Page

119 / 128

Location

Netherlands

Related Subject Headings

  • Risk Factors
  • Patient Compliance
  • Odds Ratio
  • Middle Aged
  • Male
  • Kidney Function Tests
  • Humans
  • Hemorrhage
  • Female
  • Coronary Disease